Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (51-60 of 891) with videos related to

Pageof 90
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 19, 2008
Current status of rituximab maintenance therapyJulie M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
Update on T-cell lymphomaJ M Vose
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2013
Ten years of progress in the treatment of Non-Hodgkin's LymphomaJulie M Vose
Oncology (Williston Park, N.Y.)|November 18, 2020
Use of Real-World Evidence in Hematology/Oncology Treatment OptimizationJulie M Vose
Oncology (Williston Park, N.Y.)|July 10, 2020
Fighting 2 Enemies: Cancer and COVID-19Julie M Vose
Blood|September 1, 2022
To transplant or not to transplant: that is the question in PTCLJulie M Vose
American Journal of Hematology|November 26, 2013
Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Cancer Metastasis Reviews|January 1, 1987
Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulatorsB M Vose
Oncology (Williston Park, N.Y.)|July 31, 2010
Understanding evaluation and management of primary cutaneous and systemic ALCLJulie M Vose
Hematological Oncology|February 1, 2006
Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approachJulie M Vose
Pageof 90

Showing results (51-60 of 891) with videos related to

Sort By:
Pageof 90
Clinical Advances in Hematology & Oncology : H&O|February 19, 2008
Current status of rituximab maintenance therapyJulie M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
Update on T-cell lymphomaJ M Vose
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2013
Ten years of progress in the treatment of Non-Hodgkin's LymphomaJulie M Vose
Oncology (Williston Park, N.Y.)|November 18, 2020
Use of Real-World Evidence in Hematology/Oncology Treatment OptimizationJulie M Vose
Oncology (Williston Park, N.Y.)|July 10, 2020
Fighting 2 Enemies: Cancer and COVID-19Julie M Vose
Blood|September 1, 2022
To transplant or not to transplant: that is the question in PTCLJulie M Vose
American Journal of Hematology|November 26, 2013
Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Cancer Metastasis Reviews|January 1, 1987
Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulatorsB M Vose
Oncology (Williston Park, N.Y.)|July 31, 2010
Understanding evaluation and management of primary cutaneous and systemic ALCLJulie M Vose
Hematological Oncology|February 1, 2006
Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approachJulie M Vose
Pageof 90